Non-insulin, once-daily Victoza® for type 2 diabetes is proven to lower A1C and blood sugar. Victoza® also reduces the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who are currently treating their cardiovascular disease.
Blood sugar lowering benefits
If you're struggling to get your blood sugar to goal on your current therapy, once-daily, non-insulin Victoza® may be right for you. It lowers A1C and helps lower blood sugar levels in as soon as 2 weeks.
Along with your current treatment for your cardiovascular disease, Victoza® may reduce the risk of major cardiovascular events such as heart attack, stroke, or death.
How Victoza® works
Victoza® helps your pancreas produce more insulin by helping important cells work the way they should. These cells are called beta cells, and they help control blood sugar by making and releasing insulin.
Victoza® compared with other type 2 diabetes medications, Januvia® and Byetta®, at lowering blood sugar
In medical studies that compared Victoza® with Januvia® and Byetta®, more people with type 2 diabetes taking Victoza® reached their A1C goal of <7%.